The usefulness of nerve conduction studies in objectively assessing oxaliplatin-induced peripheral neuropathy.
Andreas A
AA
Argyriou
Panagiotis
P
Polychronopoulos
Elisabeth
E
Chroni
D000200:Action Potentials; D000970:Antineoplastic Agents / Q000633:toxicity*; D004594:Electrophysiology / Q000379:methods; D006801:Humans; D008495:Medical Oncology / Q000379:methods; D009431:Neural Conduction; D009474:Neurons / Q000187:drug effects; D009944:Organoplatinum Compounds / Q000633:toxicity*; D000077150:Oxaliplatin; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin